A Policy Lens on Psychiatric Overprescribing: Federal Priorities and Provider Impact

• By: Veronica Richardson, MHA, RHIA, CHPS, CHC First Class Solutions, Inc.
• July 29th, 2026
• behavioral health policy, HHS initiatives, informed consent, Medicare fraud, OIG oversight, psychiatric overprescribing, psychotropic medications, Summer 2026 Issue, treatment planning
• 279    0

The U.S. Department of Health and Human Services (HHS) continues to emphasize its commitment to strengthening behavioral health care, including mental health and substance use treatment. In June, the agency announced more than $700 million in new funding to expand access to mental health and...

An Epidemic of Anxiety and Depression Requires a Reevaluation of Conventional Treatment

• By: Ashley Brody, MPA, CPRP Search for Change, Inc.
• September 29th, 2025
• anxiety, biomedical model, depression, Fall 2025 Issue, healthcare access, Medicaid, mental health, psychotropic medications, social determinants of health
• 4318    0

The field of psychiatry has been governed by a medical model of illness in recent decades. This model posits behavioral health conditions, including anxiety and depression, are manifestations of biological abnormalities that may be corrected through interventions commonly employed in other branches...